Intratumoral Influenza Vaccine for Early Colorectal Cancer
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The aim of this explorative phase II clinical trial is to establish the safety and efficacy
of intratumoral influenza vaccine in patients with colorectal cancer, as an additive
treatment prior to intended curative surgery.